ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway - PubMed (original) (raw)
ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway
Rensong Ye et al. Exp Mol Pathol. 2020 Apr.
Abstract
This study aimed to investigate the protective effect of angiotensin converting enzyme 2 (ACE2) on lipopolysaccharide (LPS)-induced acute lung injury (ALI). After generating ALI mouse models by injecting LPS, the levels of ACE2, inflammatory factors, and downstream proteins of the LPS-TLR4 pathway were analyzed. LPS-challenged BEAS-2B cells were established in vitro. Next, a eukaryotic expression vector, pm-ACE2, was constructed and validated. Challenged cells were transfected with pm-ACE2 containing enhanced green fluorescent protein, or they were treated with D-Ala-Ang-(1-7), angiotensin converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB) and the LPS-TLR4 pathway inhibitor dimethyl fumarate (DMF) for analysis of how the above factors contribute to ACE2 regulation. Expression of renin, Ang II, ACE and angiotensin II type 1 receptor (AT1R) was subsequently assessed. In the ALI model, mice exhibited decreased expression of ACE2, lung pathological injury, inflammatory injury, and abnormal activation of the LPS-TLR4 pathway. LPS-challenged BEAS-2B cells demonstrated upregulated expression of renin, Ang II, ACE and AT1R. After injection of ACE2, lung function and lung pathological injury were significantly improved, and that effect was accompanied by attenuated inflammation, and inactivation of the LPS-TLR4 pathway. Cell studies showed similar results. The above observations were further enhanced when there was a combined treatment with DMF and pm-ACE2. D-Ala-Ang-(1-7) treatment attenuated the protective effect of ACE2, while ACEI and ARB treatment alleviated LPS-induced pneumonic injury. In conclusion, ACE2 was expressed at low levels in response to LPS-induced ALI. Overexpression of ACE2 regulates the ACE2/Ang-(1-7)/Mas and ACE/Ang II/AT1 axes to maintain dynamic balance of the renin-angiotensin system, and attenuate inflammatory response.
Keywords: ACE/Ang II/AT1 axis; ACE2/Ang-(1–7)/mas axis; Acute lung injury; Angiotensin converting enzyme 2; LPS-TLR4 pathway; Lipopolysaccharide; Renin-angiotensin systems.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that there are no conflicts of interest.
Similar articles
- Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.
He H, Liu L, Chen Q, Liu A, Cai S, Yang Y, Lu X, Qiu H. He H, et al. Cell Transplant. 2015;24(9):1699-715. doi: 10.3727/096368914X685087. Epub 2014 Oct 6. Cell Transplant. 2015. PMID: 25291359 - Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis.
Liu J, Chen Q, Liu S, Yang X, Zhang Y, Huang F. Liu J, et al. Life Sci. 2018 Sep 1;208:139-148. doi: 10.1016/j.lfs.2018.07.013. Epub 2018 Jul 7. Life Sci. 2018. PMID: 29990483 - ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S, Kaplan M, Gamliel-Lazarovich A. Keidar S, et al. Cardiovasc Res. 2007 Feb 1;73(3):463-9. doi: 10.1016/j.cardiores.2006.09.006. Epub 2006 Sep 19. Cardiovasc Res. 2007. PMID: 17049503 Review. - Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A, Rocha GC, Magalhaes DM, Vaz LN, Salviano de Faria MH, Simoes E Silva AC. Nunes-Silva A, et al. Protein Pept Lett. 2017 Nov 17;24(9):809-816. doi: 10.2174/0929866524666170728151401. Protein Pept Lett. 2017. PMID: 28758593 Review.
Cited by
- Losartan as a Reproposing Therapeutic Agent in Acute Respiratory Distress Syndrome: Modulating Inflammatory Responses and Cytokine Production.
Sripratak K, Chamsodsai P, Siriwaseree J, Choowongkomon K, Tabtimmai L. Sripratak K, et al. Int J Mol Cell Med. 2024;13(2):120-132. doi: 10.22088/IJMCM.BUMS.13.2.120. Int J Mol Cell Med. 2024. PMID: 39184821 Free PMC article. - Causal linkage between angiotensin-converting enzyme 2 and risk of lung cancer: a bidirectional two-sample Mendelian randomization study.
Chen S, Ning R, Jiang W, Zhou S, Yu Q, Gan H. Chen S, et al. Front Med (Lausanne). 2024 Jul 8;11:1419612. doi: 10.3389/fmed.2024.1419612. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39040892 Free PMC article. - miRNA-206-3p alleviates LPS-induced acute lung injury via inhibiting inflammation and pyroptosis through modulating TLR4/NF-κB/NLRP3 pathway.
Chen M, Zhang J, Huang H, Wang Z, Gao Y, Liu J. Chen M, et al. Sci Rep. 2024 May 24;14(1):11860. doi: 10.1038/s41598-024-62733-5. Sci Rep. 2024. PMID: 38789583 Free PMC article. - A retrospective prognostic evaluation using unsupervised learning in the treatment of COVID-19 patients with hypertension treated with ACEI/ARB drugs.
Ge L, Meng Y, Ma W, Mu J. Ge L, et al. PeerJ. 2024 May 13;12:e17340. doi: 10.7717/peerj.17340. eCollection 2024. PeerJ. 2024. PMID: 38756444 Free PMC article. - Role of the RAAS in mediating the pathophysiology of COVID-19.
Jasiczek J, Doroszko A, Trocha T, Trocha M. Jasiczek J, et al. Pharmacol Rep. 2024 Jun;76(3):475-486. doi: 10.1007/s43440-024-00596-3. Epub 2024 Apr 23. Pharmacol Rep. 2024. PMID: 38652364 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous